FLOT versus FLOT/Trastuzumab/Pertuzumab perioperative therapy of human epidermal growth factor receptor 2-positive resectable esophagogastric adenocarcinoma: a randomized phase II trial of the AIO EGA study group - Hofheinz, Ralf-Dieter; Merx, Kirsten; Haag, Georg Martin; Springfeld, Christoph; Ettrich, Thomas; Borchert, Kersten; Kretzschmar, Albrecht; Teschendorf, Christian; Siegler, Gabriele; Ebert, Matthias; Goekkurt, Eray; Mahlberg, Rolf; et al. (Journal of clinical oncology, 2022)
Gesehen am 25.01.2023